SK281254B6 - Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie - Google Patents

Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie Download PDF

Info

Publication number
SK281254B6
SK281254B6 SK886-96A SK88696A SK281254B6 SK 281254 B6 SK281254 B6 SK 281254B6 SK 88696 A SK88696 A SK 88696A SK 281254 B6 SK281254 B6 SK 281254B6
Authority
SK
Slovakia
Prior art keywords
compound
dipropyl
diethyl
azaspiro
decane
Prior art date
Application number
SK886-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK88696A3 (en
Inventor
Raymond E. Dagger
Carolyn W. Grady
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of SK88696A3 publication Critical patent/SK88696A3/sk
Publication of SK281254B6 publication Critical patent/SK281254B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54—Spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
SK886-96A 1995-07-13 1996-07-08 Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie SK281254B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US113995P 1995-07-13 1995-07-13
US1606596P 1996-04-23 1996-04-23

Publications (2)

Publication Number Publication Date
SK88696A3 SK88696A3 (en) 1997-06-04
SK281254B6 true SK281254B6 (sk) 2001-01-18

Family

ID=26668617

Family Applications (1)

Application Number Title Priority Date Filing Date
SK886-96A SK281254B6 (sk) 1995-07-13 1996-07-08 Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie

Country Status (29)

Country Link
EP (1) EP0753512B1 (xx)
JP (1) JP3949750B2 (xx)
KR (1) KR100404832B1 (xx)
CN (1) CN1067378C (xx)
AR (1) AR003452A1 (xx)
AT (1) ATE164154T1 (xx)
AU (1) AU716256B2 (xx)
BG (1) BG62359B1 (xx)
CA (1) CA2181006C (xx)
CZ (1) CZ289617B6 (xx)
DE (1) DE69600189T2 (xx)
DK (1) DK0753512T3 (xx)
EA (1) EA000037B1 (xx)
ES (1) ES2113765T3 (xx)
HK (1) HK1010052A1 (xx)
HU (1) HU226691B1 (xx)
IL (1) IL118815A (xx)
MA (1) MA23936A1 (xx)
MX (1) MX9602767A (xx)
NO (1) NO306672B1 (xx)
NZ (1) NZ286951A (xx)
PL (1) PL191019B1 (xx)
RO (1) RO117376B1 (xx)
SG (1) SG43383A1 (xx)
SK (1) SK281254B6 (xx)
TR (1) TR199600579A2 (xx)
TW (1) TW419462B (xx)
UA (1) UA42749C2 (xx)
UY (1) UY24283A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60125780D1 (de) * 2000-08-08 2007-02-15 Daiichi Seiyaku Co Verfahren zur herstellung von bicyclischen verbindungen und deren zwischenstufen
US20070015780A1 (en) * 2003-03-10 2007-01-18 Picker Donald H Method of treating cancer with azaspirane compositions
CN104119321B (zh) * 2013-04-28 2017-09-08 齐鲁制药有限公司 二氢吲哚酮衍生物的二马来酸盐及其多晶型物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3211397A1 (de) * 1982-03-27 1983-11-10 Hoechst Ag, 6230 Frankfurt Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US4430335A (en) * 1983-02-09 1984-02-07 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1-azaspiro[4,5]decanes and their analgesic compositions
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
PT100566B (pt) * 1991-06-07 1999-06-30 Smithkline Beecham Corp Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso
GB9122735D0 (en) * 1991-10-25 1991-12-11 Smithkline Beecham Corp Methods
GB9217116D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt

Also Published As

Publication number Publication date
NZ286951A (en) 1998-02-26
IL118815A (en) 2000-06-29
HUP9601918A2 (en) 1997-09-29
IL118815A0 (en) 1996-10-31
BG62359B1 (bg) 1999-09-30
JPH09118618A (ja) 1997-05-06
EA199600048A3 (ru) 1997-03-31
AU716256B2 (en) 2000-02-24
UY24283A1 (es) 2001-10-25
TR199600579A2 (tr) 1997-01-21
CZ203696A3 (en) 1997-03-12
BG100710A (bg) 1997-03-31
AU5945596A (en) 1997-01-23
EA000037B1 (ru) 1998-02-26
MX9602767A (es) 1998-01-31
HK1010052A1 (en) 1999-06-11
CA2181006C (en) 2007-04-03
MA23936A1 (fr) 1997-04-01
CN1067378C (zh) 2001-06-20
NO306672B1 (no) 1999-12-06
UA42749C2 (uk) 2001-11-15
TW419462B (en) 2001-01-21
KR100404832B1 (ko) 2004-01-13
JP3949750B2 (ja) 2007-07-25
PL191019B1 (pl) 2006-03-31
ATE164154T1 (de) 1998-04-15
DE69600189T2 (de) 1998-10-15
DK0753512T3 (da) 1998-10-19
DE69600189D1 (de) 1998-04-23
RO117376B1 (ro) 2002-02-28
CN1140710A (zh) 1997-01-22
EP0753512A1 (en) 1997-01-15
CZ289617B6 (cs) 2002-03-13
PL315191A1 (en) 1997-01-20
SK88696A3 (en) 1997-06-04
AR003452A1 (es) 1998-08-05
EP0753512B1 (en) 1998-03-18
EA199600048A2 (ru) 1996-12-30
CA2181006A1 (en) 1997-01-14
NO962931L (no) 1997-01-14
SG43383A1 (en) 1997-10-17
KR970069987A (ko) 1997-11-07
HU226691B1 (en) 2009-06-29
ES2113765T3 (es) 1998-05-01
HUP9601918A3 (en) 1998-01-28
NO962931D0 (no) 1996-07-12
HU9601918D0 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
KR100514963B1 (ko) 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
HU181238B (en) Process for preparing amine derivatives of di-o-/n-higher alkyl or -alkenyl/-propandiols
EP0545194B1 (en) Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
EP2415472A1 (en) Solid pharmaceutical composition containing amorphous body of solifenacin
EA027869B1 (ru) Стабилизированная композиция такролимуса
EP3867256A1 (en) New forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making
AU611494B2 (en) Stabilized pergolide compositions
US5114948A (en) Stabilized pergolide compositions
US6475525B1 (en) Oral preparations containing forskolin derivatives and process for producing pharmaceutical preparations
US5952365A (en) 2- 2-(Dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro 4.5!decane dimaleate
SK281254B6 (sk) Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie
US6482417B2 (en) Stable pharmaceutical formulation comprising torsemide modification II
US5744495A (en) N, N-diethyl-8, 8-dipropyl-2-azaspiro 4.5! decane-2-propanamine
US5939450A (en) N,N-dimethyl-8,8-dipropyl-2-azaspiro 4.5!decane-2-propanamine dimaleate
MXPA96002767A (en) Dimalate of n, n-dietil-8,8-dipropil-2-azaspiro [4,5] decane-2-propanam
EP1264821B1 (en) Novel crystal of stilbene derivative and process for producing the same
JP3377219B2 (ja) 経口抗菌組成物
JPH04247030A (ja) 抗菌剤組成物
WO2005023790A1 (en) (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid sodium salt
JPH04247031A (ja) 抗菌性組成物
WO2005023789A1 (en) Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid